Orange Book product · Generic (ANDA)
HALOPERIDOL
HALOPERIDOL
At a glance
Jan 08, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 08, 2020
6 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
HALOPERIDOL
Strength
0.5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 211061
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HALOPERIDOL
- —HALDOLBrand (NDA)
NDA 015921 · ORTHO MCNEIL
- —HALDOL SOLUTABBrand (NDA)
NDA 017079 · ORTHO MCNEIL PHARM
- 2026HALOPERIDOLGeneric (ANDA)
ANDA 214470 · ALEMBIC
- 2026HALOPERIDOLGeneric (ANDA)
ANDA 071130 · AIPING PHARM INC
- 2025HALOPERIDOLGeneric (ANDA)
ANDA 218162 · CREEKWOOD PHARMS
- 2024HALOPERIDOLGeneric (ANDA)
ANDA 218789 · AUROBINDO PHARMA LTD
- 2024HALOPERIDOLGeneric (ANDA)
ANDA 216918 · MANKIND PHARMA
- 2022HALOPERIDOLGeneric (ANDA)
ANDA 216004 · MSN
- 2022HALOPERIDOLGeneric (ANDA)
ANDA 200854 · ACTAVIS GROUP
- 1989HALOPERIDOLGeneric (ANDA)
ANDA 072727 · LEDERLE
- 1989HALOPERIDOLGeneric (ANDA)
ANDA 072728 · LEDERLE
- 1989HALOPERIDOLGeneric (ANDA)
ANDA 072729 · LEDERLE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
